Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fada Xia

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Frontiers in Cell and Developmental Biology|April 4, 2022
circSSU72 Promotes Cell Proliferation, Migration and Invasion of Papillary Thyroid Carcinoma Cells by Targeting miR-451a/S1PR2 AxisZeyu Zhang, Fada Xia, Lei Yao, et al.
Gland Surgery|May 10, 2021
The systemic immune-inflammation index-based model is an effective biomarker on predicting central lymph node metastasis in clinically nodal-negative papillary thyroid carcinomaZeyu Zhang, Fada Xia, Wenlong Wang, et al.
World Journal of Surgical Oncology|September 28, 2024
BRAF V600E mutation in thyroid carcinoma: a large-scale study in Han Chinese populationRong Cong, Hui Ouyang, Di Zhou, et al.
Frontiers in Medicine|September 13, 2021
Role of Immune Cell-Specific Hypermethylation Signatures in Classification and Risk Stratification of Breast CancerYong Chen, Fada Xia, Bo Jiang, et al.
Scientific Reports|November 25, 2025
Clinical significance of level VII lymph node metastasis in papillary thyroid cancerHui Ouyang, Xinying Li, Fada Xia, et al.
Biology Direct|June 25, 2026
The role of ESRRA and JUNB in oxyphil cells: insights from spatial transcriptomics and single-cell transcriptomics in uremic secondary hyperparathyroidismZeyu Zhang, Xiangyuan Qiu, Botao Sun, et al.
Cancer Cell International|February 22, 2020
Hsa_circ_0011385 accelerates the progression of thyroid cancer by targeting miR-361-3pFada Xia, Yong Chen, Bo Jiang, et al.
Cancer Management and Research|February 26, 2019
DNA methylation-mediated silencing of miR-204 is a potential prognostic marker for papillary thyroid carcinomaFada Xia, Wenlong Wang, Bo Jiang, et al.
Gland Surgery|January 24, 2022
Preoperative application of carbon nanoparticles in bilateral axillo-breast approach robotic thyroidectomy for papillary thyroid cancerHui Ouyang, Fada Xia, Zhejia Zhang, et al.
Frontiers in Genetics|September 9, 2022
A prognostic exosome-related LncRNA risk model correlates with the immune microenvironment in liver cancerDuntao Su, Zeyu Zhang, Zhijie Xu, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Frontiers in Cell and Developmental Biology|April 4, 2022
circSSU72 Promotes Cell Proliferation, Migration and Invasion of Papillary Thyroid Carcinoma Cells by Targeting miR-451a/S1PR2 AxisZeyu Zhang, Fada Xia, Lei Yao, et al.
Gland Surgery|May 10, 2021
The systemic immune-inflammation index-based model is an effective biomarker on predicting central lymph node metastasis in clinically nodal-negative papillary thyroid carcinomaZeyu Zhang, Fada Xia, Wenlong Wang, et al.
World Journal of Surgical Oncology|September 28, 2024
BRAF V600E mutation in thyroid carcinoma: a large-scale study in Han Chinese populationRong Cong, Hui Ouyang, Di Zhou, et al.
Frontiers in Medicine|September 13, 2021
Role of Immune Cell-Specific Hypermethylation Signatures in Classification and Risk Stratification of Breast CancerYong Chen, Fada Xia, Bo Jiang, et al.
Scientific Reports|November 25, 2025
Clinical significance of level VII lymph node metastasis in papillary thyroid cancerHui Ouyang, Xinying Li, Fada Xia, et al.
Biology Direct|June 25, 2026
The role of ESRRA and JUNB in oxyphil cells: insights from spatial transcriptomics and single-cell transcriptomics in uremic secondary hyperparathyroidismZeyu Zhang, Xiangyuan Qiu, Botao Sun, et al.
Cancer Cell International|February 22, 2020
Hsa_circ_0011385 accelerates the progression of thyroid cancer by targeting miR-361-3pFada Xia, Yong Chen, Bo Jiang, et al.
Cancer Management and Research|February 26, 2019
DNA methylation-mediated silencing of miR-204 is a potential prognostic marker for papillary thyroid carcinomaFada Xia, Wenlong Wang, Bo Jiang, et al.
Gland Surgery|January 24, 2022
Preoperative application of carbon nanoparticles in bilateral axillo-breast approach robotic thyroidectomy for papillary thyroid cancerHui Ouyang, Fada Xia, Zhejia Zhang, et al.
Frontiers in Genetics|September 9, 2022
A prognostic exosome-related LncRNA risk model correlates with the immune microenvironment in liver cancerDuntao Su, Zeyu Zhang, Zhijie Xu, et al.
Pageof 7